Company intelligence / Profile preview

NIRSense

Richmond, Virginia, United Statesnirsense.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

NIRSense has developed ruggedized, wireless patient monitors using proprietary Total Oximetry™ technology for continuous noninvasive measurement of arterial and tissue oxygenation. Devices are proven in extreme environments through U.S. military partnerships and are being adapted for broader civilian healthcare use. The company is expanding into cognitive state monitoring using wearable fNIRS-based systems.

Therapeutic areas: CardiovascularNeurology
Modalities: DeviceWearable biosensor
Industry: Physiological Monitoring

Partnerships

U.S. Department of Defense / Defense Innovation Unit / Navy / Army / Air Force stakeholdersNaval Medical Research Command–Naval Advanced Medical DevelopmentMedical Technology Enterprise Consortium

Beyond the preview

Go deeper on NIRSense.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NIRSense.

Explore the full profile